Streetbeat News

Price Targets

RLAY

B of A Securities analyst Jason Gerberry maintains a Buy rating on Relay Therapeutics and raises the price target from $20 to $24.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:55 pm

CUBE

RBC Capital has initiated coverage on CubeSmart with an Outperform rating and set a price target of $56.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:54 pm

BFLY

Butterfly Network shares rose after Lake Street initiated coverage with a Buy rating and a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:53 pm

RBRK

Truist Securities analyst Joel Fishbein maintains a Buy rating on Rubrik (NYSE:RBRK) with a $43 price target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:50 pm

AAPL

JP Morgan analyst Samik Chatterjee has reiterated an Overweight rating on Apple (NASDAQ:AAPL) and maintained a price target of $265.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:49 pm

VRDN

BTIG analyst Julian Harrison has maintained a Buy rating on Viridian Therapeutics and raised the price target from $46 to $56, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:47 pm

JBI

Jefferies analyst Philip Ng maintains a Buy rating on Janus International Group (NYSE:JBI) but lowers the price target from $15 to $12.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:46 pm

APP

Jefferies analyst James Heaney maintains a Buy rating on AppLovin and raises the price target from $105 to $108.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:45 pm

ORCL

Jefferies analyst Brent Thill maintains a Buy rating on Oracle and raises the price target from $150 to $170.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 3:41 pm